Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BoYueZhiYuan Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 1
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Biopharma
  • Pharmaceutical
Summary

The typical case for the fund is to invest in rounds with 5 participants. The meaningful sponsors for the fund in investment in the same round are Quan Capital, Qiming Venture Partners, New Horizon Capital.

The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017. The fund is constantly included in less than 2 investment rounds annually.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Health Care, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Qiagen Suzhou Translational Medicine

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
15th Rock Ventures Japan, Tokyo
A-Round Capital -
Bauer Venture Partners Germany, Hamburg
Canary Ventures Canarias, Las Palmas, Spain
Gotham Green Partners California, Santa Monica, United States
Holly Group Holdings China, Hong Kong, Hong Kong Island
Jiangyi Chuangtou China, Japan, Kagoshima Prefecture
Kamunting Street Capital -
Kendall Family Foundation Boston, Massachusetts, United States
Neome Herzliya, Israel, Tel Aviv
Pergament LOHAS Fund New York, New York, United States
PMC Partners England, London, United Kingdom
Southwestern Ontario Development Fund -
Sprout Venture Partners Bangalore, India, Karnataka
Thai Union Group Samut Sakhon, Samut Sakhon Province, Thailand
TRIREC Central Region, Singapore, Singapore
Venture Technologies Mississippi, Ridgeland, United States
Zhongke Venture Capital China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Qiagen Suzhou Translational Medicine

Biopharma
Health Care
Pharmaceutical
$27M07 Jul 2017 Jiangsu

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BoYueZhiYuan Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: